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Cognitive anosognosia and 
behavioral changes in probable 
Alzheimer’s disease patients
Corina Satler1, Carlos Tomaz2
ABSTRACT. Anosognosia, impairment insight and unawareness of deficits are used as equivalent terms in this study. 
Objective: To investigate the relationship between the presence of anosognosia symptoms and cognitive domains, functional 
abilities, and neuropsychiatric symptoms in patients with probable Alzheimer’s disease (pAD) and elderly controls (EC). 
Methods: Twenty-one pAD (14 women) and twenty-two EC (16 women) were submitted to a neuropsychological battery of 
tests assessing global cognitive status, and specific cognitive functions: memory, executive and attention functions, verbal 
fluency and visuoconstructive abilities. Additionally, functional abilities (FAQ) and neuropsychiatric symptoms (NPI) were 
measured. Results: The linear regression statistical test found general anosognosia to be associated with subjective memory 
complaints, age and Arithmetic-DRS in the EC group. On the other hand, cognitive and functional abilities scores (Arithmetic- 
DRS, IQCODE and FAQ) were the best predictors in pAD patients, particularly for behavioral awareness. Conclusion: These 
results indicated that different variables are associated with self-awareness for pAD patients and EC, but for both groups 
executive functions appear to play an important role, contributing particularly to awareness of behavioral changes.
Key words: awareness, anosognosia, insight, aging, Alzheimer’s disease, dementia.
ANOSOGNOSIA COGNITIVA E ALTERAÇÕES COMPORTAMENTAIS EM PACIENTES COM PROVÁVEL DOENÇA DE ALZHEIMER
RESUMO. Anosognosia, comprometimento do insight e ausência de reconhecimento de déficits são usados como termos 
equivalentes neste estudo. Objetivo: Investigar a relação entre a presença de sintomas de anosognosia e domínios 
cognitivos, habilidades funcionais, e sintomas neuropsiquiátricos em pacientes com provável doença de Alzheimer (pAD) e 
idosos controles. Métodos: vinte e um pDA (14 mulheres) e vinte e dois EC (16 mulheres) foram submetidos a uma bateria 
neuropsicológica de testes avaliando o estado cognitivo global, e funções cognitivas específicas: memória, funções executivas 
e atencionais, fluência verbal e habilidades visoconstrutivas. Adicionalmente, habilidades funcionais (FAQ) e sintomas 
neuropsiquiátricos (NPI) foram avaliados. Resultados: Teste estatístico de regressão linear indicou uma associação entre 
anosognosia e queixas subjetivas de memória, idade e aritmética-DRS no grupo controle. Por outro lado, aritmetica-DRS, 
IQCODE e FAQ (habilidades cognitivas e funcionais) foram melhores predictores nos pacientes com pDA, especificamente para 
consciência das alterações comportamentais. Conclusão: Os resultados indicaram que diferentes variáveis estão associadas 
com auto-percepção nos pacientes com pDA e controles, porém para ambos os grupos parece que o funcionamento 
executivo tem um papel importante contribuindo principalmente na percepção das alterações comportamentais.
Palavras-chave: percepção, anosognosia, consciência, envelhecimento, doença de Alzheimer, demência.
INTRODUCTION
The term “anosognosia” was originally coined to describe the lack of insight 
into hemiplegia following right hemisphere 
stroke.1 It is important to note that, whereas 
insight was once considered relevant only to 
hemiplegia, it is now recognized as applicable 
to cognitive and behavioral domains affected 
by neurological disorders other than stroke, 
such as dementia.1 In this article, “anosogno-
sia” and the equivalent terms “impaired in-
sight” and “unawareness of deficits” are used 
in this strict sense.
Alzheimer’s disease (AD) is the most com-
mon form of dementia, and is a pathology 
where we can observe anosognosia symp-
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toms2,3 that can occur in up to 81% of individuals with 
AD.4 However, there is considerable inter-person vari-
ability in the presentation of anosognosia in AD.5
Among AD patients, studies have demonstrated that 
anosognosia is common in early stages of the disease, 
and have suggested that impairment of insight increas-
es with severity of the dementia.6
Previous studies seeking to identify the association 
between awareness of cognitive deficits in AD have 
shown mixed results. In short, the mechanisms under-
lying insight in AD remain unclear. For example, some 
authors2,5,7 have found a significant correlation between 
unawareness of deficits and global cognitive function, 
using the Mini-Mental State Examination (MMSE) or 
Clinical Dementia Rating (CDR). In contrast, other re-
searchers have not found evidence of this association.8
In addition, some studies have also found relation-
ships between psychiatric symptoms and anosognosia 
in AD.2,7,9
More specifically, it has been demonstrated that 
there is a difference between the absence of perception 
of cognitive deficits and of behavioral disorders. Studies 
have described that AD patients show impaired insight 
for memory and cognitive deficits, and daily living activ-
ities deficits, which constitute core symptoms of AD, but 
also for a range of other possible symptoms including 
different cognitive deficits, and psychiatric symptoms 
such as depression, anxiety, or irritability.9 However, 
there is no clear evidence that anosognosia for cognitive 
deficits and behavioral alterations in AD differs with 
functional and neuropsychological performance.
One example of the awareness of memory deficits 
in dementia is the presence of subjective memory com-
plaints that reflect preservation of the ability to recog-
nize and evaluate one’s own deficits. Global cognitive 
function would be a pre-requisite for appropriate judg-
ment. Thus, Leicht, Berwing, and Gertz3 described that 
while AD patients tended to overestimate their cogni-
tive abilities, in older adults without cognitive impair-
ment there is an underestimation of ability.
It has been reported that memory complaints are a 
feature that seem to be common among middle-aged 
and older adults without dementia,10,11 and that the 
prevalence of memory complaints tends to be higher 
as age increases. For example, in the Maastricht Aging 
Study, the prevalence of forgetfulness among volun-
teers was 41% in the group aged 55 to 65 years and 52% 
in the 70 to 85 year-old age group.10
Jorm and colleagues,12 in a community sample study, 
described that memory complaints were associated with 
poorer cognitive test performance, more prominent 
mood symptoms, personality characteristics and poor 
physical health. In other words, cognitive performance 
was not only contributed to by memory complaints.
In the present study, we attempted to examine the 
presence of lack of awareness of specific deficits (in-
tellectual functioning and behavioral changes) in AD 
patients, and explore a possible relationship with cog-
nitive and neuropsychiatric profiles and functional 
impairments.
In order to examine the presence of anosognosia in 
elderly adults without cognitive impairment, we also 
explored the relationship between awareness of deficits 
and cognitive performance.
METHODS
Participants. We carried out a case control study in a con-
venience sample of 43 participants, 21 of whom were pa-
tients diagnosed with probable AD (pAD) and 22 healthy 
elderly controls (EC). pAD patients were recruited from 
a larger pool of participants at the Geriatric Medical 
Center, University Hospital of Brasilia, Brasilia, Brazil, 
and were examined by a social worker, a neuropsycholo-
gist, and a geriatrician. Healthy controls were recruited 
from the community or were spouses of the patients 
and were examined with a comprehensive neuropsy-
chological and neuropsychiatry evaluation, and had no 
history of either neurological or psychiatric disorders, 
including traumatic brain injury or substance abuse.
All AD patients met the clinical diagnostic criteria of 
AD described by the National Institute of Neurological 
and Communicative Diseases and Stroke-Alzheimer’s 
Disease and Related Disorders Association.13 The diag-
noses by the study geriatricians were based on the neu-
ropsychological, medical, and laboratory findings. The 
severity of AD ranged from mild to moderate (scores 1 
or 2) according to the Clinical Dementia Rating scale.14 
All patients exhibited a 1 to 4-year history of progres-
sive cognitive impairment, predominantly affecting 
memory, which was confirmed by their caregiver using 
the short version of the IQCODE (Informant Question-
naire on Cognitive Decline in the Elderly),15 but showed 
normal consciousness and lived with their families and 
required no special care.
All patients and control volunteers had normal or 
corrected-to-normal vision and hearing. The neuropsy-
chiatric Inventory was applied to all subjects.16 If any ev-
idence of behavior disturbance or significant depression 
was noted after the interview, the subject was excluded.
Instruments and procedures. After confirming the diag-
nosis for those patients that met the inclusion criteria 
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of the study and selection of participants for the con-
trol group, the neuropsychological evaluation was per-
formed on each individual in both groups by the same 
investigator. All participants were evaluated using the 
neuropsychological tests during two sessions on sepa-
rate days (with an interval of 7 days), and tests were al-
ways applied in the same order.
Neuropsychological assessments. As part of the initial as-
sessment, standardized neuropsychological tests were 
used to assess different cognitive functions.
Global Cognition Score. A Brazilian version of the 
MMSE,17 and the Mattis Dementia Rating Scale (DRS), 
was used.18 In addition, the Vocabulary subtest (the 
Wechsler Adult Intelligence Scale – WAIS-III)19 was used 
as a measure of premorbid intelligence.
Memory. The Digit Span Forward (DRS)18 and Corsi’s 
Block-Tapping Test20 assessed short-term memory (ver-
bal and visual memory, respectively).
The Auditory Verbal Learning Test (RAVLT)21 was 
used for assessing the learning curve, strength of mem-
ory after interference task, and pattern of learning (se-
rial positioning effects), as well as for measuring recog-
nition memory.
The 15-item version of the Boston Naming Test 
(BNT) in Consortium to Establish a Registry for Al-
zheimer’s Disease22 measured the ability to name 
pictures of objects (semantic memory), and the Rey-
Osterrieth Complex Figure (ROCF) – recall20 assessed 
nonverbal memory.
Executive and Attention Functions. Executive function 
and attention measures were assessed using the follow-
ing tests: the Clock Drawing Test (CDT) - to command,23 
Wisconsin Card Sort Test (WCST) - modified version,24 
the Weigl Test,20 the Stroop Color-Word Test (SCWT)20 
and the 5-Point Test (FPT).20 These tests evaluated plan-
ning, set shifting, selective attention, speed of visuomo-
tor coordination, and divided attention.
Additionally, all participants performed simple 
arithmetic tasks (addition, multiplication, subtraction, 
division) using the Arithmetic subtest - DRS18 and men-
tal manipulation of well learned sequences was assessed 
by the Mental Control subtest - DRS.18 
Verbal Fluency. Verbal fluency tests such as Animal nam-
ing and words beginning with letters “FAS”20 were used 
to evaluate phonological and lexical retrieval in oral 
modality.
Visuoconstructive Abilities. The CDT - copy23 and the 
ROCF - copy20 were used to assess visuospatial skills. In 
the CDT, subjects are asked to draw a clock and to set 
the time at 45 past two. This task is used as a test of 
constructional abilities, but also requires some level of 
executive control.
Measure of functional abilities. These values were ob-
tained using a questionnaire instrument filled in by an 
informal caregiver, such as a family member. The Pfef-
fer Functional Activities Questionnaire – FAQ25 was 
used to identify the level of functionality of the subjects 
required in the instrumental activities of their daily 
routine.
Additionally, subjective memory complaints were 
analyzed using a self-report memory questionnaire – 
MAC-Q.26
Neuropsychiatric symptoms. The Neuropsychiatric Inven-
tory (NPI) was used to measure psychopathology in the 
participants; this measure was also developed specifi-
cally for use with dementia. The NPI rates the severity 
and frequency of 12 neuropsychiatric disturbances that 
are common in dementia: delusions, hallucinations, agi-
tation, dysphoria, anxiety, apathy, irritability, euphoria, 
disinhibition, aberrant motor behavior, night-time be-
havior disturbances, and appetite and eating abnormali-
ties together with the related caregivers’ distress.
Depressive mood was assessed using the Cornell 
Scale for Depression in Dementia (CSDD).27
As with the measures of functional abilities, the 
same informal caregiver was interviewed by the asses-
sor who filled in the scales.
Anosognosia symptoms assessment. The Brazilian version 
of the Anosognosia Questionnaire-Dementia (AQ-D)28 
was used in this study. Originally, this questionnaire 
was devised to examine the effects of clinical variables, 
such as cognitive functions and the presence of neuro-
psychiatric symptoms, on these domains of anosogno-
sia in patients with AD.
The AQ-D is a 42-item questionnaire collecting re-
sponses from both patients and their caregivers about 
the current level of impairment of patients. The AQ-D 
consists of questions divided into two sections: The 
first section assesses intellectual functioning, while 
the second section examines changes in interests and 
personality. Each answer is rated as never (0 points), 
sometimes (1 point), usually (2 points), or always pres-
ent (3 points). Thus, higher scores indicate more severe 
impairments.
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Form A is answered by the patient alone (with clari-
fications by the examiner if needed), whereas form B (a 
similar questionnaire written in the third person) is an-
swered by the patient’s caregiver blind to the patient’s 
answers in form A.
The final score is the subtraction of scores in forms A 
from scores in form B. Thus, positive scores indicate that 
the caregiver rated the patient as more impaired than 
the patient’s own evaluation (the patient was less aware 
of his or her cognitive and emotional deficits).
All participants were tested individually in a room 
with normal interior lighting. 
Ethical aspects. Written, informed consent in accordance 
with the ethical guidelines for research with human sub-
jects (196/96 CNS/MS resolution) was obtained from all 
participants and their caregivers (where appropriate). 
The study was approved by the Human Subject Com-
mittee of the Faculty of Medicine, University of Brasilia.
Statistical methods. A descriptive analysis (means and 
standard deviation) was undertaken for the socio-de-
mographic variables of the sample. In order to evaluate 
the neuropsychological data, t tests for independent 
samples were performed for each test.
Pearson’s correlation coefficient was employed for 
correlation of scores between AD-Q and the other in-
struments. Linear regression models were used to eval-
uate the association between the anosognosia scores 
(total score, behavioral changes score and intellectual 
functioning score) and the cognitive processes, the level 
of functionality of the subjects and neuropsychiatric 
symptoms.
The significance level was set at p<0.05 (two-tailed) 
for all tests.
RESULTS
Socio-demographic characteristics of patients and con-
trols are depicted in Table 1.
Mean age was 74 years (pAD patients: 78.62±6.66 
years; EC: 71.00±6.85 years), school education was 9.62 
years on average (pAD patients: 6.81±4.08 years; EC: 
12.32±4.42 years). Groups did not differ significantly 
with respect to these variables [age (p=0.864), educa-
tion (p=0.808)]; however, pAD patients were older and 
had less formal education than EC.
Group performance was similar for the IQCODE 
test (p=0.583) and the MAC-Q (p=0.429). Notably, 
the scores for both groups on the MAC-Q were higher 
than the cut-off score (<25), (pAD patients: 26.10±5.77; 
EC: 25.45±6.61) suggesting the presence of subjective 
Table 1. Demographic characteristics in AD patients and elderly controls
AD (n=21) EC (n=22)
Age (years) 78.62±6.66 71.00±6.85
Range 65-88 65-84
Gender (M:F) 7:14 8:16
Education level (years) 6.81±4.08 12.32±4.42
Range 15-04 12-04
FAQ** 19.19±7.27 0.32±1.04
NPI total score* 17.33±12.09 6.23±7.45
CSDD total score* 10.33±6.91 5.50±3.88
IQCODE score 3.90±0.60 2.88±0.52
MAC-Q score 26.10±5.77 25.45±6.61
AQ-D cognitive changes score** 25.48±16.15 5.45±7.72
AQ-D behavioral changes score* 8.81±10.31 3.23±5.74
AQ-D total score** 34.76± 24.77 8.95±12.25
AD: Alzheimer’s disease; EC: Elderly controls; M:F: Male:Female; FAQ: Functional Activities 
Questionnaire; NPI: Neuropsychiatric Inventory; CSDD: Cornell Scale for Depression in Dementia; 
IQCODE: Informant Questionnaire on Cognitive Decline in Elderly; MAC-Q: Memory Complaint 
Questionnaire; AQ-D: Anosognosia Questionnaire for Dementia. Values expressed as means±SD 
or Percentage. *p<0.05; **p<0.01 (Student’s t-test).
memory complaints. Additionally, it is also important 
to note that the pAD patients showed higher scores on 
the CSDD compared to EC (p=0.009).
Neuropsychological assessment. Neuropsychological re-
sults are listed in Table 2 and revealed a significant 
main difference among EC and pAD patients which 
reached statistical significance on most tests except the 
5-Point Test–perseverations (p=0.713). In general, t 
tests showed that pAD patients performed significantly 
worse than EC.
AQ-D Intellectual functioning. The performance of the 
AD group on two cognitive tests (DRS – total and FPT – 
unique designs) was inversely associated with the degree 
of anosognosia (r(2) = 0.748; p<0.001), which explained 
51.1% of the variance (DRS - total score: 42.1% and FPT 
– unique designs: 9%). Additionally, two other variables 
contributed positively to the increase of anosognosia 
symptoms: Letter FAS (15.8%) and NPI (7.9%). For the 
EC group, MAC-Q score and age variables were inversely 
associated with degree of anosognosia (R(2)=0.38; p= 
0.004), explaining 38% of the variance (MAC-Q: 26.2% 
and age: 12.2%) (Table 3).
AQ-D behavior changes. In the AD group, cognitive and 
functional abilities were associated with degree of 
anosognosia (R(2)=0.835; p<0.001), which explained 
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Table 2. Test performance of AD patients and elderly controls.
Measure AD EC
Global cognition score
MMSE, n/ 30** 18.00±4.29 28.64±1.39
DRS, n/ 144** 113.33±8.45 139.27±3.70
Vocabularysubtest (WAIS-R)** 32.48±10.14 49.27±8.33
Short-term memory
Digit Span Forward (DRS)** 4.95±1.32 6.64±1.13
Corsi’ Block-TappingTest Forward* 4.81±1.91 6.50±1.94
Episodic recall
RAVLT
 Trial 1 2.00±1.61 5.45±1.43
 Trial 2 2.90±2.09 7.77±1.82
 Trial 3 3.38±2.24 9.59±2.42
 Trial 4 3.76±2.11 9.72±1.93
 Trial 5 4.04±2.65 11.00±1.87
 Delayed Recall 0.95±2.15 8.36±2.40
 Delayed Recognition –9.38±14.05 10.86±3.50
Semantic recall
BNT, n/ 15** 12.48±2.13 15±0.00
Nonverbal recall
ROCF - Recall** 3.00±3.13 18.00±6.10
Working Memory
Digit Span Backward (DRS)** 2.62±1.39 4.41±1.18
Corsi’ Block Test Backward** 2.81±1.53 5.23±1.27
Calculation ability 
Arithmeticsubtest (DRS)** 3.33±0.61 7.50±0.85
Executive and Attention functions 
CDT – To command** 7.38±2.51 9.82±0.50
WCST – Categories** 1.57±1.59 4.05±1.67
WCST – Total errors** 20.14±12.28 7.27±5.74
FPT – Unique designs** 5.19±4.39 18.41±7.71
FPT – Perseverations, % 2.43±2.78 2.14±2.37
StroopTest – Interference condition,n/32** 13.95±8.05 27.27±5.60
Mental Control subtest (DRS)** 5.29±2.77 8.68±0.64
Verbal Fluency
Letters (FAS)** 16.86±10.05 36.45±10.63
Categories (animal) 5.57±2.74 17.77±4.33
Visuoconstructive abilities
CDT - copy** 4.57±2.95 9.55±0.85
ROCF - copy** 19.12±12.13 33.5±2.63
AD: Alzheimer’s disease; EC: Elderly controls; MMSE: Mini-Mental State Examination; DRS: Mattis Dementia Rating Scale; RAVLT: Rey’s auditory verbal learn-
ing test, trial 1 - trial 5, delayed recall score is the number of words reproduced from the 15 words given, recognition range 0 - 30 (score of 15 is chance 
and 30 indicates complete recognition);50 BNT: Boston Naming test; ROCF: Rey-Osterrieth Complex Figure; CDT: Clock Drawing test; WCST: Wisconsin Card 
Sorting test; FPT: Five-Point test. Values expressed as means±SD. * p < 0.05; ** p < 0.01 (Student’s t-test). Higher test scores indicate better performances.
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83.5% of the variance (IQCODE test: 44.1%, FAQ: 19%, 
Arithmetic subtest: 19%, Stroop test – interference con-
dition: 3.7%, and RAVLT- delayed recall: 5.2% being in-
versely proportional). For the EC group, performance on 
two cognitive tasks (Arithmetic subtest - DRS and Mental 
control subtest - DRS) was associated with the presence 
of anosognosia symptoms focused on behavior changes 
(R(2)=0.403; p=0.003). Both cognitive variables ex-
plained 40.3% of the variance (Arithmetic subtest - DRS: 
27.3% and Mental control subtest - DRS: 13%) (Table 3).
AQ-D total score. In the AD group, cognitive and func-
tional abilities scores were associated with degree of 
anosognosia (R(2)=0.821; p<0.001), which explained 
80% of the variance (IQCODE test: 38.8%, FAQ: 23.4%, 
Arithmetic subtest - DRS: 13.6% and BNT: 6.3%; where 
the latter variable was inversely proportional to the 
presence of anosognosia symptoms) (Table 3).
For the EC group, three variables were associated 
with the presence of anosognosia symptoms (R(2)= 
0.572; p<0.001), which explained 57.2% of the variance: 
Arithmetic subtest – DRS (29.9%), MAC-Q (16.8%) and 
age (10.5%). Two of these variables, MAC-Q and age, 
were inversely proportional to anosognosia symptoms 
(Table 3).
DISCUSSION
The aim of this study was to explore a possible relation-
ship between the presence of anosognosia symptoms 
Table 3. Significant variables associated with anosognosia symptoms.
b EP T p-value R2 F gl p-value
AQ-D Intellectual Functioning
EC Constant 56.53 16.52 3.42 0.003
0.38 7.55 2.19 0.004MAC-Q –0.76 0.21 –3.67 0.002
Age –0.45 0.20 –2.22 0.038
AD Patients Constant 200.80 28.88 6.96 <0.001 
0.75 15.85 4.16 <0.001
DRS total score –1.66 0.28 –6.02 <0.001
FPT – Unique designs –1.65 0.45 –3.65 0.002
Letters (FAS) 0.86 0.24 3.61 0.002
NPI 0.38 0.15 2.51 0.023
AQ-D Behavior changes
EC Constant –55.62 15.87 –3.50 0.002
0.4 8.10 2.19 0.003Arithmetic subtest (DRS) 3.82 1.12 3.39 0.003
Mental Control subtest (DRS) 3.48 1.50 2.32 0.032
AD Patients Constant –63.35 8.80 –7.20 <0.001 
0.83 21.31 5.15 <0.001
Arithmetic subtest (DRS) 2.20 0.42 5.29 <0.001
IQCODE 12.33 2.01 6.11 <0.001
FAQ 0.72 0.15 4.86 <0.001
RAVLT – delayed recall –1.29 0.52 –2.47 0.026
Stroop – interference cond. 0.30 0.14 2.15 0.048
AQ-D Total score
EC Constant 42.11 32.22 1.31 0.208
0.572 10.36 3.18 <0.001
Arithmetic subtest (DRS) 5.33 2.18 2.45 0.025
MAC-Q –1.05 0.29 –3.63 0.002
Age –0.65 0.28 –2.38 0.029
AD Patients Constant –41.33 32.20 –1.28 0.217
0.821 23.96 4.16 <0.001
Arithmetic subtest (DRS) 4.10 0.97 4.25 0,001
IQCODE 17.55 4.90 3.58 0.002
FAQ 2.05 0.34 6.04 0,000
BNT –3.65 1.37 –2.65 0.017
AD: Alzheimer’s disease; EC: Elderly controls; AQ-D: Anosognosia Questionnaire in Dementia; MAC-Q: Memory Complaint Questionnaire; DRS: Mattis Dementia Rating Scale; FPT: Five-Point test; NPI: 
Neuropsychiatric Inventory; IQCODE: Informant Questionnaire on Cognitive Decline in Elderly; FAQ: Functional Activities Questionnaire; RAVLT: Rey’s auditory verbal learning test; BNT: Boston Naming test.
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and cognitive domains, functional abilities, and neuro-
psychiatric symptoms in pAD patients and normal el-
derly controls.
The main finding of this study was a significant 
difference between groups regarding the presence of 
anosognosia symptoms. Results showed that pAD pa-
tients were less accurate in evaluating the level of their 
awareness of cognitive and behavioral changes than 
healthy older adults, as evidenced by a larger discrepan-
cy between self-and informant ratings on the AQ-D in 
pAD patients compared to EC. These findings corrobo-
rate a long line of research that suggests the presence of 
anosognosia for cognitive deficits and behavioral chang-
es is a common and early feature of AD.7
AD patients and anosognosia. Examining awareness of 
intellectual functioning, results showed a strong asso-
ciation with global cognitive functioning (DRS – total 
score). A similar result has been described by Sato and 
colleagues29 using the same anosognosia questionnaire 
(AD-Q), and the MMSE as a screening test for dementia. 
Thus, our findings showing that preserved awareness 
was associated with more intact cognitive functioning 
supports previous research.2,6,7,30
Furthermore, the association between verbal and 
design fluency tasks (FAS test and FPT respectively) 
with intellectual awareness suggests that pAD patients 
who have poor executive functioning might show more 
anosognosia for intellectual deficits, as described by 
other studies,31 including an association with specific 
brain alterations such as those involving frontal lobe 
regions.32
Loss of awareness, as well as psychosis and apathy, 
has been associated with neuropsychological changes in 
right frontal and related subcortical structures.4 Simi-
larly, our findings showed a modest association between 
awareness for cognitive deficits and the NPI suggesting 
that pAD patients with behavioral disturbances failed to 
appreciate the degree of their cognitive impairment and 
often under-estimated it.
Levels of unawareness of behavioral changes were as-
sociated with higher scores on the IQCODE. These find-
ings suggested that pAD patients with impaired insight 
were described by their caregivers and family members 
as having more cognitive changes over the last 10 years.
We also found an association between behavioral 
awareness and functional abilities (FAQ), a finding also 
described by previous studies.29,33 This association sug-
gests that patients with a higher level of independence 
have more insight about self-care, in contrast to pa-
tients that exhibit functional impairment.
pAD patients with functional impairment are unable 
to perform some complex tasks, such as cooking, man-
aging their finances, shopping, using the telephone, and 
taking medications. Considering that these activities 
require a greater variety of cognitive abilities, usually in-
volving higher order cognitive processes,34 several stud-
ies have described that cognitive impairment is strongly 
associated with alterations in IADL.35,36 Along the same 
lines, Barberger-Gateau and colleagues37 found a rela-
tionship between performance on neuropsychological 
tests and measures of IADL and high risk for developing 
dementia.
In addition, our findings showed that results on neu-
ropsychological tests were associated with loss of aware-
ness of behavioral problems, namely, math skills such 
as numerical and calculation tasks (Arithmetic subtest 
– DRS), attention and response inhibition (Stroop test), 
and delayed recall of word-list (RAVLT – delayed recall).
In the area of arithmetic, there are differences in 
the strategies people use to solve an arithmetic prob-
lem. For example, the same person might solve a simple 
subtraction problem by counting and solve another by 
retrieving the answer from memory.38 Arithmetic fact 
retrieval is very likely to involve lexical processes, in that 
arithmetic facts appear to be represented in the same 
memory system that supports world retrieval, called 
“semantic memory”. Thus, according to the literature, 
multiplication sums such as 3 x 4 = 12 are assumed to 
be stored in long-term memory.39
In addition, several studies have shown the role of 
the prefrontal cortex in mathematical performance, 
particularly in actual mathematical calculation or rea-
soning.40 In school-age children and adolescents, math-
ematical skills are associated with executive functions 41, 
and Bull and Scerif42 have also noted the role of specific 
executive functions, such as working memory and inhi-
bition in mathematical proficiency.
In the Stroop test, the incongruent condition con-
sists of naming the color of ink in which a color name is 
printed when the color is incongruent with the name. 
This condition elicits the Stroop effect that implies a sig-
nificant slowing of performance. The response tendency 
or task set of reading the word, through life-long expe-
rience with reading is initially activated more strongly 
than the novel response tendency or task set naming 
the color. A number of studies have shown a deficit in 
Stroop test performance by patients with pAD, and evi-
dence suggests that this deficit is due to a breakdown 
in inhibitory processes that occurs early in the course 
of the disease.43 These results are in line with those ob-
tained by other studies suggesting that pathology for 
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frontal brain regions is typically associated with execu-
tive dysfunction and also with poor behavioral insight.44
It is also found that episodic memory impairments 
(word recall - RAVLT) are associated with an increase in 
behavioral awareness. Difficulty with the acquisition of 
new information is generally the first and most salient 
symptom to emerge in patients with pAD. Studies de-
scribe the loss of episodic memory as the core feature of 
the dementing processes,45 and these observations are 
consistent with findings that brain structures known to 
be critical to episodic recall, such as the hippocampus 
and neighboring regions, show pathological alterations 
in pAD patients.46,47 In addition, there is evidence that 
the delayed recall score of word-list learning tasks, such 
as RAVLT, is the best neuropsychological parameter for 
discriminating pAD patients from healthy controls.48
Previous studies have described an association be-
tween anosognosia and behavioral changes in pAD pa-
tients, and have correlated the lack of awareness of their 
deficits with disease progress, and marked cognitive and 
functional impairment.2,5,30
Despite the relative lack of awareness of the severity 
of everyday cognitive declines and behavioral changes 
(total score in AD-Q), our findings showed that the same 
main factors that specifically contributed to behavioral 
awareness (IQCODE, FAQ, and Arithmetic subtest - 
DRS), were also associated with general anosognosia, 
suggesting that behavioral changes tend to be a better 
predictor of anosognosia in AD patients.
Regarding a possible association between anosogno-
sia and symptoms of depressed mood in AD patients, 
our results showed that the lack of awareness of their 
deficits is not influenced by the presence of depressed 
symptoms, as described by another studies.2,4,28,30
Elderly controls and anosognosia. In the evaluation of el-
derly controls, there was a negative association between 
awareness for intellectual functioning and subjective 
memory complaints. Consequently, those elderly that 
reported subjective memory complaints seemed able to 
pay attention to their own cognitive functioning and ex-
hibit preservation in self-awareness.
These findings are in agreement with previous stud-
ies describing that memory complaints are frequent in 
healthy elderly population.11,49 However, given perfor-
mance levels of these participants on neuropsychological 
tests were according to their age and educational level, it 
can be said that participants’ complaints of memory are 
not an accurate reflection of real memory disturbance. 
Thus, it seems the over-estimation in healthy Brazilian 
elders may be related to cultural factors.
Regarding awareness of behavioral changes, our 
findings showed that math skills (Arithmetic subtest 
– DRS) and executive control (Mental control subtest 
– DRS) were associated with awareness of behavioral 
problems, suggesting executive functions are involved 
in this process. Although elderly controls did not exhibit 
high anosognosia scores, an interesting pattern was ob-
served similar to that observed in pAD patients.
When analyzing total scores, the variables that 
contributed to intellectual functioning and behavioral 
changes were associated with general anosognosia. 
The findings differ in this regard from the general pat-
tern observed in pAD patients where mainly behavioral 
changes contributed to general anosognosia.
Considered as a whole, we found that different vari-
ables were associated with self-awareness for pAD pa-
tients and elderly controls, but for both groups it seems 
that executive functions play an important role in con-
tributing to awareness of behavioral changes.
Our findings in this report are subject to at least four 
limitations. First, data on the educational level of rela-
tives or proxies were not collected, and this point should 
be addressed in further studies since this may have in-
fluenced the IQCODE results. Second, the diagnosis of 
anosognosia was based on cut-off scores on a severity 
rating scale rather than on valid diagnostic criteria for 
anosognosia. Third, this study investigated awareness 
deficits in pAD patients considering discrepancies be-
tween informant and self-reports in order to establish 
anosognosia. Although this approach can be valid when 
shown to correspond to objective performance, it is po-
tentially influenced by informants’ personal character-
istics and prone to inaccuracy, as reported by Zanetti 
and colleagues.50 Finally, the small sample size is a 
shortcoming that limits this study, and any conclusion 
should be interpreted with caution. Therefore, further 
studies, including larger samples of controls and pAD 
patients, as well as other neuropsychological tests, are 
necessary to assess the association with awareness of 
deficits in the early stage of AD.
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